How COVID-19 Has Impacted the Care Continuum for NSCLC Patients

How COVID-19 Has Impacted the Care Continuum for NSCLC Patients

How COVID-19 Has Impacted the Care Continuum for NSCLC Patients
RestartResume

How can we safely treat our patients with non-small cell lung cancer during the COVID-19 pandemic?

  • Overview

    The COVID-19 pandemic has presented a unique and difficult problem for clinicians and patients alike. Here to share how he’s continuing treatment for his patients with non-small cell lung cancer in the era of COVID-19 is Dr. Joshua Bauml, a medical oncologist and Assistant Professor at the Perelman School of Medicine at the University of Pennsylvania.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free